Z-0632-2022 Class II Terminated

Recalled by DePuy Orthopaedics, Inc. — Warsaw, IN

FDA device recall Z-0632-2022 was initiated by DePuy Orthopaedics, Inc. on January 5, 2022 and is designated Class II. Reason for recall: May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur. The recall status is terminated (terminated December 22, 2023). Affected quantity: 3 units.

Recall Details

Product Type
Devices
Report Date
February 16, 2022
Initiation Date
January 5, 2022
Termination Date
December 22, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 units

Product Description

ATTUNE REVISION DISTAL FEMORAL AUGMENT SZ 6 4MM- Intended as a Component in total knee arthroplasty (TKA) revision surgeries Product Number: 154706001

Reason for Recall

May have adhesive residue on the posterior surface of the femoral augment, if undetected prior to implantation, soft tissue irritation and/or infection may occur.

Distribution Pattern

US Nationwide distribution in the states of TN, TX.

Code Information

Lots: JJ3389 GTIN: 10603295382775